New therapies developed to treat non-small cell lung cancer are not reaching all patients with this disease. Human-created barriers bar the way for those experiencing real or perceived stigma and those who reside in remote places or live on little income.
In this supplement, Abbie Begnaud, MD, FCCP, hones in on this human-created dichotomy and discusses the problems and possible solutions, along with diagnostic and treatment options.